Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| NOVADEL PHARMA INC | 3 568 372 | déclaré | 31 déc. 2009 | tx 23+5 178 372 |
| INKINE PHARMACEUTICAL CO INC | 22 500 | déclaré | 02 juin 2003 | tx 5+122 500 |
| EAGLE PHARMACEUTICALS, INC. | 16 253 | déclaré | 07 mars 2023 | tx 30+143 637−34 054 |
| AXONYX INC | 10 000 | déclaré | 19 juin 2008 | tx 7+194 158 |
| CIMA LABS INC | 0 | déclaré | 12 août 2004 | tx 14+25 000−104 155 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 07 mars 2023 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 16 253 | 0.00 USD | deriv |
| 28 févr. 2022 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 11 200 | 0.00 USD | deriv |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 8.78 USD | |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 8.78 USD | |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 4.42 USD | |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 08 avr. 2021 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 28 févr. 2020 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 8.78 USD | |
| 28 févr. 2020 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 02 févr. 2021 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 13 500 | 0.00 USD | deriv |
| 05 janv. 2020 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 04 mars 2019 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 4.04 USD | |
| 04 mars 2019 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 23 janv. 2019 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 07 janv. 2018 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 18 déc. 2017 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.90 USD | |
| 18 déc. 2017 | EXERCISE | EAGLE PHARMACEUTICALS, INC. | 2 340 | 0.00 USD | deriv |
| 04 janv. 2017 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 03 avr. 2014 | PURCHASE | EAGLE PHARMACEUTICALS, INC. | 3 950 | 12.79 USD | 1er après silence |
| 12 déc. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 1 300 | 75.07 USD | |
| 13 déc. 2016 | SALE | EAGLE PHARMACEUTICALS, INC. | 8 700 | 75.00 USD | |
| 04 janv. 2016 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 21 avr. 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 10 000 | 0.00 USD | deriv |
| 13 mars 2015 | GRANT_AWARD | EAGLE PHARMACEUTICALS, INC. | 5 000 | 0.00 USD | deriv |
3 achats déclarés après au moins 12 mois de silence — dernière occurrence le 03 avr. 2014.